Fact checked byErik Swain

Read more

November 05, 2023
2 min read
Save

News you may have missed from the 2023 Cardiometabolic Health Congress

Fact checked byErik Swain
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Healio and Cardiology Today have aggregated news you may have missed from the 2023 Cardiometabolic Health Congress in Boston.

News from CMHC included discussion of the relationship between antihypertensive treatment and poor sleep; the importance of early diagnosis and treatment intensification for diabetes; novel therapeutics to treat high triglycerides; and more.

Meeting mic_Adobe_224451506
Healio and Cardiology Today have aggregated news you may have missed from the 2023 Cardiometabolic Health Congress in Boston.
Image: Adobe Stock

Sleep and hypertension: A two-way street of risks

Data show sleep abnormalities are associated with hypertension; however, antihypertensive medications can in turn disrupt sleep, complicating treatment for patients, according to a speaker. Read more

Early diagnosis, treatment intensification essential to improve diabetes outcomes

Interventions that prevent or delay the onset of type 2 diabetes are critically important, and early diagnosis and treatment intensification can improve outcomes and increase lifespan. Read more

VIDEO: Diagnosis of diabetes requires individualized assessment

In this Healio video exclusive, Anne L. Peters, MD, delineates how the diagnosis of diabetes is heterogeneous and requires clinicians to “individualize our assessment of patients, and therefore our treatment of patients.” Read more

VIDEO: Low-dose colchicine can address residual inflammatory risk

In this Healio video exclusive, Paul M. Ridker, MD, MPH, discusses the use of low-dose colchicine to target inflammation in patients who remain at high CVD risk despite controlled LDL. Read more

After many failed trials, novel therapeutics may finally tackle high triglycerides

After years of failed clinical trials with agents to lower severely elevated triglycerides, emerging therapeutics hold promise for effectively addressing hypertriglyceridemia and reducing associated CV risks, a speaker reported. Read more

Prioritize, optimize sleep to reap cardiometabolic benefits

Simple steps to optimize poor sleep habits can translate to large gains in cardiometabolic health, including improvements in BP, insulin resistance and even appetite regulation. Read more

VIDEO: Which is the superior method for weight loss – drugs or surgery?

In this Healio video exclusive, Donna H. Ryan, MD, and Christopher Still, DO, FACP, discuss the optimal treatment strategy for patients who require weight loss beyond diet and lifestyle changes. Read more

Home blood pressure measurements ‘missed opportunity’ to tackle CV risk

Out-of-office BP measurements provide the clearest picture of CV risk for patients and are the ideal method to diagnose and treat hypertension, yet most clinicians still rely on inaccurate clinic readings. Read more

VIDEO: Insulin delivery systems for type 2 diabetes vary

In this Healio video exclusive, Viral Shah, MD, discusses insulin delivery systems for patients with type 2 diabetes. Read more

With little evidence, CGM benefits for people without diabetes ‘largely hypothetical’

Continuous glucose monitoring is becoming a mainstay of care for people with type 1 and type 2 diabetes, yet providers should be cautious about the technology’s application for people without diabetes looking for a “wellness” tool. Read more